COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 2051: Articles 20501-20510  | Next

COVID-19 optimal vaccination policies: a modeling study on efficacy, natural and vaccine-induced immunity responses
Acuna-Zegarra, M. A., Diaz-Infante, S., Baca-Carrasco, D., Olmos Liceaga, D.
10.1101/2020.11.19.20235176 — Posted: 2020-11-20
Risk of evolutionary escape from neutralizing antibodies targeting SARS-CoV-2 spike protein
Van Egeren, D., Novokhodko, A., Stoddard, M., Tran, U., Zetter, B., Rogers, M., Pentelute, B. L., Carlson, J. M., Hixon, M. S., Joseph-McCarthy, D., Chakravarty, A.
10.1101/2020.11.17.20233726 — Posted: 2020-11-20
CLINICAL APPLICATIONS OF MACHINE LEARNING ON COVID-19: THE USE OF A DECISION TREE ALGORITHM FOR THE ASSESSMENT OF PERCEIVED STRESS IN MEXICAN HEALTHCARE PROFESSIONALS.
Delgado-Gallegos, J. L., Aviles-Rodriguez, G., Padilla-Rivas, G. R., Cosio-Leon, M. d. l. A., Franco-Villareal, H., Zuniga-Violante, E., Romo-Cardenas, G. S., Islas-Cisneros, J. F.
10.1101/2020.11.18.20233288 — Posted: 2020-11-20
The detection and stability of the SARS-CoV-2 RNA biomarkers in wastewater influent in Helsinki, Finland
Hokajarvi, A.-M., Rytkonen, A., Tiwari, A., Kauppinen, A., Oikarinen, S., Lehto, K.-M., Kankaanpaa, A., Gunnar, T., Al-Hello, H., Blomqvist, S., Miettinen, I. T., Savolainen-Kopra, C., Pitkanen, T.
10.1101/2020.11.18.20234039 — Posted: 2020-11-20
Modeling and Sensitivity Analysis of Coronavirus Disease(COVID-19) Outbreak Prediction
Sedaghat, A., Oloomi, S. A. A., Ashtian Malayer, M., Band, S. S., MOSAVI, A., Nadai, L.
10.1101/2020.11.18.20234419 — Posted: 2020-11-20
Rapid and lasting generation of B-cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 disease and convalescence
Hartley, G. E., Edwards, E. S. J., Aui, P. M., Varese, N., Stojanovic, S., McMahon, J., Peleg, A. Y., Boo, I., Drummer, H. E., Hogarth, P. M., O'Hehir, R. E., van Zelm, M. C.
10.1101/2020.11.17.20233544 — Posted: 2020-11-20 Discussion: Onsite
Remdesivir induced viral RNA and subgenomic RNA suppression, and evolution of viral variants in SARS-CoV-2 infected patients.
Boshier, F. A. T., Pang, J., Penner, J., Hughes, J., Parker, M., Shepherd, J. G., Alders, N., Bamford, A., Grandjean, L., Grunewald, S., Hatcher, J., Best, T., Dalton, C., Bynoe, P. D., Frauenfelder, C., Koeglmeier, J., Myerson, P., Roy, S., Williams, R., The COVID-19 Genomics UK (COG-UK) Consortium, , Thomson, E. C., de Silva, T. I., Goldstein, R. A., Breuer, J.
10.1101/2020.11.18.20230599 — Posted: 2020-11-20
Secondary Attack Rate (SAR) in household contacts of expired primary cases of COVID-19: A study from Western India
Shah, K., Desai, N., Mavalankar, D.
10.1101/2020.11.17.20231290 — Posted: 2020-11-20
REACT-1 round 6 updated report: high prevalence of SARS-CoV-2 swab positivity with reduced rate of growth in England at the start of November 2020
Riley, S., Ainslie, K. E. C., Eales, O., Walters, C. E., Wang, H., Atchinson, C., Fronterre, C., Diggle, P. J., Ashby, D., Donnelly, C. A., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P.
10.1101/2020.11.18.20233932 — Posted: 2020-11-20
Cov-MS: a community-based template assay for clinical MS-based protein detection in Sars-Cov-2 patients
Van Puyvelde, B., Van Uytfanghe, K., Tytgat, O., Van Oudenhove, L., Gabriels, R., Bouwmeester, R., Daled, S., Van Den Bossche, T., Ramasamy, P., Verhelst, S., De Clerck, L., Corveleyn, L., Debunne, N., Wynendaele, E., De Spiegeleer, B., Judak, P., Roels, K., De Wilde, L., Van Eenoo, P., Reyns, T., Cherlet, M., Dumont, E., Debyser, G., t'Kindt, R., Sandra, K., Gupta, S., Drouin, N., Harms, A., Hankemeier, T., Jones, D., Gupta, P., Lane, C., El Ouadi, S., Vincendet, J.-B., Morrice, N., Oehrle, S., Tanna, N., Silvester, S., Hannam, S., Sigloch, F., Bhangu-Uhlmann, A., Claereboudt, J., Razavi, M., Anderson, N. L., Degroeve, S., Cuypers, L., Stove, C., Lagrou, K., Martens, G. A., Deforce, D., Martens, L., Vissers, H., Dhaenens, M.
10.1101/2020.11.18.20231688 — Posted: 2020-11-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).